Table 1 Demographic and participant characteristics within the full sample (n = 918) and benzodiazepine use groups (n = 905) (n, %).
Past 12 Month Benzodiazepine Use Groupsa | ||||
|---|---|---|---|---|
Participant Characteristics | Full Sample n = 918 | None n = 725 | Once/monthly use n = 62 | Weekly/daily use n = 118 |
Age | ||||
<50 | 254 (27.7%) | 192 (26.5%) | 25 (40.3%) | 37 (31.4%) |
50–64 | 387 (42.2%) | 306 (42.2%) | 27 (43.5%) | 47 (39.8%) |
≥65 | 277 (30.2%) | 227 (31.3%) | 10 (16.1%) | 34 (28.8%) |
Years post-injury | ||||
2–14 years | 115 (12.5%) | 93 (12.8%) | 9 (14.5%) | 12 (10.2%) |
15–29 years | 560 (61.0%) | 451 (62.2%) | 34 (54.8%) | 69 (58.5%) |
≥30 years | 243 (26.5%) | 181 (25.0%) | 19 (30.6%) | 37 (31.4%) |
Race-ethnicity | ||||
Non-Hispanic White | 639 (69.7%) | 484 (66.8%) | 50 (80.6%) | 100 (85.5%) |
Non-Hispanic Black | 229 (25%) | 203 (28.0%) | 7 (11.3%) | 12 (10.3%) |
Hispanic/Other | 49 (5.3%) | 38 (5.2%) | 5 (8.1%) | 5 (4.3%) |
Injury level | ||||
C1–4 | 62 (7%) | 46 (6.5%) | 4 (6.5%) | 11 (9.7%) |
C5-C8, non-ambulatory | 179 (20.1%) | 138 (19.6%) | 12 (19.4%) | 27 (23.9%) |
Non-cervical, non-ambulatory | 262 (29.4%) | 210 (29.9%) | 17 (27.4%) | 32 (28.3%) |
Ambulatory | 388 (43.5%) | 309 (44.0%) | 29 (46.8%) | 43 (38.1%) |
Veteran (yes) | 112 (12.3%) | 96 (13.3%) | 5 (8.1%) | 8 (6.8%) |
Education | ||||
HS diploma/GED or less | 360 (40.1%) | 286 (40.2%) | 22 (35.5%) | 43 (37.4%) |
Associate’s/two-year degree | 243 (27.1%) | 188 (26.4%) | 20 (32.3%) | 34 (29.6%) |
Bachelor’s or higher | 295 (32.9%) | 237 (33.3%) | 20 (32.3%) | 38 (33.0%) |
Household income | ||||
<$25,000 | 394 (45.2%) | 303 (43.8%) | 34 (55.7%) | 52 (46.4%) |
$25,000–$74,999 | 285 (32.7%) | 236 (34.2%) | 14 (23.0%) | 34 (30.4%) |
>$75,000 | 192 (22.0%) | 152 (22.0%) | 13 (21.3%) | 26 (23.2%) |
